>>20976410
>>20976413
>>20976427
We need to dig on BioTexCon…
https://www.geneticsandsociety.org/biopolitical-times/risky-business-company-behind-stranded-surrogacy-babies-also-promoting
In 2011, an Italian couple returned home with a baby born from a Ukrainian surrogate in an arrangement facilitated by BioTexCom. After mandatory DNA testing by Italian officials, the baby was found to have no genetic link to the intended parents, preventing them from being officially recognized as the parents. (The child was eventually adopted by a different couple in Italy.)
Alleging that the 2011 case was not an isolated incident—and presumably informed by the 2012 revelations of a “baby-selling ring” in which Ukrainian fertility companies had taken part in creating “an inventory of unborn babies” for unsuspecting parents—Ukrainian authorities in 2018 initiated investigations into BioTexCom. Prosecutors requested permission to conduct genetic testing for more than 200 children throughout Europe and in China. They chargedBioTexCom’s owner Albert Tochilovsky and its head physician with human trafficking, document forgery, and tax evasion, and placed Tochilovsky temporarily under house arrest. It appears that the case has not gone to trial. Tochilovsky, who has owned BioTexCom since 2012, claimed that the 2011 case was “before his time” and, in any case, was a simple embryo mix-up that should only be subject to administrative penalties.
In 2019, an Australian reporter uncovered the case of Baby Bridget, whose American intended parents refused to take custody after she was born prematurely and required significant medical care. At the age of 3, she had spent most of her life in hospitals and had been placed in a children’s home in Ukraine. There she received care and therapy for a range of disabilities while awaiting Ukrainian citizenship, without which she could not be placed for adoption. Tochilovsky claims that Bridget’s intended parents were never clients at his clinic and that there must be another clinic impersonating BioTexCom to ruin its reputation.
The business model: “Cheapest surrogacy in Europe”
BioTexCom is the major player in Ukraine’s booming surrogacy market, which is fueled by poverty and instability in the country. It’s right there on the website: “The cheapest surrogacy in Europe is in Ukraine, the poorest country in Europe.” Tochilovsky claims that BioTexCom handles one quarter of the surrogacy market in the world and 70% of the market in Ukraine.
The company differentiates itself from other fertility clinics and surrogacy agencies by offering all-inclusive packages, including a “Guaranteed Success” package for IVF with a money-back guarantee if after five cycles there is no pregnancy that passes twelve weeks. Their surrogacy packages, starting at €34,900, offer unlimited IVF cycles for surrogates if using donor eggs (patients are limited to two egg retrievals using their own eggs).
BioTexCom offers prospective customers a luxury experience, with accommodations in “high-class hotels,” as well as meals, a driver, and even a local cell phone all provided by the clinic. Their “VIP Package” for €64,900 goes beyond the standard all-inclusive surrogacy deal (€34,900) by including sex selection, extra compensation for surrogates who carry twins, and a jump to the head of the line (less than four months wait versus up to a year in the standard surrogacy package).
A massive full-service operation supports these all-inclusive offerings. BioTexCom owns and operates not just the clinic space, but also apartments, hotels, a logistics team, and private cars and drivers. This kind of “vertical integration” is rarely seen in the fertility industry, even in cross-border surrogacy agencies that specialize in “reproductive tourism.” Tochilovsky has plans to extend his business empire horizontally too, hoping to eventually commercialize fringe biotechnologies that are ethically troubling and far from ready to move into the clinic, like artificial wombs and lab-grown human organs.